HHLR Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$3.86M Hold
2022
Q2
$3.04M Hold
2022
Q1
$4.03M Hold
2021
Q4
$7.26M Hold
2021
Q3
$18.2M Hold
2021
Q2
$16.7M Sell
2021
Q1
$27.1M Sell
2020
Q4
$53.7M Hold
2020
Q3
$22.6M Buy